Statistics about Health, Pharma & Medtech in Japan
Statistics
- Number of installed PET scanners Japan 2002-2020
- Production value of medical mirrors Japan 2019-2022
- Largest in-vitro diagnostics markets in Asia 2016-2028
- Medical device revenue in Japan 2019-2029, by segment
- Revenue of the endoscopic devices segment Japan 2016-2029
- Share of medical device production value Japan 2022, by category
- Revenue of the medical devices industry in Japan 2019-2029
- Revenue of the cardiology devices segment Japan 2016-2029
- Production value of manual wheelchairs Japan 2018-2022
- Sales value of electric wheelchairs Japan 2018-2022
- Consumer trust in medical advice from generative AI worldwide in 2023, by generation
- Consumers who trust medical advice from generative AI worldwide in 2023, by country
- Diabetes medical devices and drugs market size Japan FY 2017-2024
- Production value of electric wheelchairs Japan 2018-2022
- Sales value of manual wheelchairs Japan 2018-2022
- Domestic medical ICT market size in Japan FY 2018-2023
- Usage of health apps & smart health devices in Japan 2017
- Level of willingness to trust and accept AI in healthcare worldwide in 2022
- Number of mental health consultations at health care centers Japan FY 2013-2022
- Number of mental health and welfare consultations Japan FY 2022, by reason
- Share of people buying products and services to improve mental wellbeing Japan 2022
- Number of patients with mental disorders Japan 2020, by age and patient type
- Number of mental health consultations Japan FY 2022, by contact method
- Number of mental health consultations over telephone Japan FY 2013-2022
- Share of people using digital technology for mental wellness Japan 2022
- Share of people feeling more stressed or anxious during the past year Japan 2022
- Number of patients with mental and behavioral disorders Japan 1996-2020, by type
- Number of patients with affective disorders Japan 1996-2020, by gender
- Share of people having worries or stress Japan 2019, by gender and age
- Number of forced mental illness hospitalizations by legal control Japan FY 2013-2022
- Cumulative number of mental disability certificates Japan FY 2014-2022
- Number of inpatients with mental and behavioral disorders Japan 1996-2020, by type
- Number of consultations on child abuse at child guidance centers Japan FY 2012-2021
- Most practiced methods to improve mental wellbeing Japan 2022
- Breakdown of drug-dependent patients based on diagnosis Japan 2022
- Number of outpatients with mental and behavioral disorders Japan 1996-2020, by type
- Share of establishments implementing measures for mental health Japan 2023, by size
- Most common contact person employees consulted about stress Japan 2023, by gender
- Number of patients with mental disorders Japan 2020, by age and illness type
- Cumulative number of mental disability certificates Japan FY 2022, by degree
- Number of involuntary hospitalizations for mental illnesses Japan FY 2013-2022
- Share of establishments with mentally unwell absent employees Japan 2023, by industry
- Share of establishments implementing stress level tests Japan 2023, by size
- Number of patients with mental and behavioral disorders Japan 2020, by classification
- Share of people actively working on mental wellbeing Japan 2022
- Frequency of mental health professional visits in Japan 2018
- Number of patients with mental disorders Japan 1996-2020, by patient type
- Number of patients with schizotypal or delusional disorder Japan 1996-2020, by gender
- Consultation cases on sexual child abuse at child guidance centers Japan FY 2012-2021
- Breakdown of drug-dependent patients based on main drug use Japan 2022
- Consultation cases on child abuse at child guidance centers Japan FY 2021, by type
- Number of patients with Alzheimer's Japan 1996-2020, by gender
- Consultation cases on psychological child abuse Japan FY 2012-2021
- Share of office workers feeling mentally unstable amid COVID-19 Japan 2021
- Share of establishments with mentally unwell absent employees Japan 2023, by size
- Number of patients with mental disorders per 100,000 inhabitants Japan 1996-2020
- Forced mental illness hospitalizations per 100,000 inhabitants Japan FY 1997-2021
- Consultation cases on physical child abuse Japan FY 2012-2021
- Alfresa's self-medication products wholesale business net sales FY 2014-2018
- Alfresa's medical-related business net sales FY 2015-2018
- Number of medical errors reported to JQ Japan 2013-2022, by report type
- Alfresa's net income FY 2013-2017
- Estimated amount of blood donations Japan 2013-2021
- Taisho Pharmaceutical's female manager share FY 2013-2020
- Japanese Red Cross's revenue from blood services FY 2016-2019
- Estimated amount of blood donations Japan 2021, by type
- Pharmaceutical spending Japan FY 2018-2024
- Number of blood donors Japan 2013-2021
- Alfresa's ethical pharma wholesale business net sales FY 2014-2018
- Alfresa's female manager rate FY 2015-2017
- Alfresa's net sales FY 2013-2022
- Alfresa's net sales FY 2017, by segment
- Alfresa's manufacturing business net sales FY 2014-2018
- Alfresa's self-medication product wholesale business sales FY 2020, by product
- Taisho Pharmaceutical's net sales FY 2012-2021
- Number of blood donors Japan 2021, by age group
- Number of blood donations Japan 2021, by type of donation
- Alfresa's employee numbers FY 2015-2017
- Number of blood donors Japan 2021, by gender
- Alfresa's operating profit FY 2013-2018
- Distribution of blood donors Japan 2021, by donation site
- Japanese Red Cross's revenue from blood services FY 2021, by segment
- Japanese Red Cross's expenditure on blood services FY 2021, by segment
- Alfresa's operating profit FY 2017, by segment
- Alfresa's market capitalization FY 2013-2017
- Alfresa's ethical pharma wholesaling business sales FY 2020, by product category
- Taisho Pharmaceutical's operating profit FY 2013 to 2018
- Number of life sciences PCT applications in Japan by area 2009-2012
- Level of experience with drugs among teenagers Japan 2023
- Taisho Pharmaceutical's gross profit FY 2013-2021
- Alfresa's manufacturing business sales FY 2017, by field
- Annual growth rate of pharmaceutical spending in Japan FY 2018-2024
- Japanese Red Cross's expenditure on blood services FY 2016-2019
- Taisho Pharmaceutical's net income FY 2013-2020
- Taisho Pharmaceutical's total assets FY 2013-2020
- Taisho Pharmaceutical's R&D expenditures FY 2013-2020
- Taisho Pharmaceutical's employee number FY 2013-2020
- Import value of medical products to Japan 2012-2021
- Number of quasi-drugs approved by PMDA Japan FY 2013-2022
- Non-prescription drugs market shipment value in Japan 2010-2019